| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.4174 | 19 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.6069 | 30 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.7989 | 21 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.1337 | 23 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.6768 | 21 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.3025 | 29 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.7624 | 16 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.5849 | 39 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.4699 | 43 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.3964 | 46 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 42.5594 | 15 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 42.1105 | 14 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.1827 | 49 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.8737 | 22 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.6226 | 44 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.7146 | 40 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.7514 | 40 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 42.257 | 14 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.3003 | 38 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.1823 | 33 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.1737 | 33 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.4157 | 34 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 39.3962 | 5 |